Toxicity OF Fluoropyrimidines: A Comparative Study of the Cardiotoxicity of capEcitabine and tEysuno

Trial Profile

Toxicity OF Fluoropyrimidines: A Comparative Study of the Cardiotoxicity of capEcitabine and tEysuno

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Capecitabine; Oxaliplatin
  • Indications Colorectal cancer; Gastric cancer; Liver cancer; Oesophageal cancer; Pancreatic cancer
  • Focus Adverse reactions
  • Acronyms TOFFEE
  • Most Recent Events

    • 09 Dec 2015 Planned End Date changed from 5 Jan 2015 to 30 Dec 2017 as reported by United Kingdom Clinical Research Network record.
    • 13 Jun 2015 Planned End Date changed from 5 Sep 2015 to 5 Jan 2015 as reported by United Kingdom Clinical Research Network record.
    • 15 Nov 2014 Accrual to Date is 13% according to United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top